en 
Deutsch 
Española 
Italiano 
Français 
Polski 
Nederlands 
Svenska (Sverige) 
Czech (Čeština) 
DHB-MED 100 (Dihydroboldenone Cypionate)
• CAS number: 65-06-5
• Molecular Weight: 288.43 g/mol
• Formula: C19H28O2
DHB-MED 100 by DEUS MEDICAL®
DHB-MED 100 (Dihydroboldenone Cypionate)
Overview
DHB-MED 100 (Dihydroboldenone Cypionate) is an analogue of testosterone. It is useful in hormone replacement therapy, the treatment of breast cancer, osteoporosis and decreased libido. It is manufactured as dihydroboldenone cypionate 100mg/ml injection, containing dihydroboldenone cypionate 100mg and excipients.
Dihydroboldenone Cypionate Mechanism of Action
Dihydroboldenone cypionate acts on androgen receptors, exhibiting moderate androgenic properties, but high anabolic properties. It can be used in hormonal replacement therapy. It is also used to stimulate muscle growth, development and fat distribution.
Dihydroboldenone Cypionate Dosage
100mg weekly by intramuscular injection, max of 400mg monthly.
Dihydroboldenone Cypionate Side effects
Virilization prostate enlargement, nausea, vomiting, skin colour changes, priapism swelling of feet.
✓ Dihydroboldenone Cypionate . . . . . . 100mg
✓ Excipients . . . . . . . . . . . . . . . . . . . . . q.s
Precautions for storage:
Because of the high concentration of the product, it is susceptible to crystallization when exposed to colder temperatures. It’s best to follow the process of re-dissolving the product if this has happened. Crystallization does not impact patient safety, efficacy, or product quality.
BECOME A PARTNER
We are offering a diverse range of pharmaceutical products, which are available only from an authorized resellers. Our highly-regarded partners are comprised of industry experts who share our values and commitment. Our goal is to strengthen our network of prestigious professionals who strive to deliver great quality products.
We believe that partnerships are essential to drive change, innovation and transformation, and we are committed to ensuring the success of our collaborations.